ETON
NASDAQ HealthcareEton Pharmaceuticals, Inc. - Common Stock
Drug Manufacturers - Specialty & Generic
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
�� 市场数据
| 价格 | $25.04 |
|---|---|
| 成交量 | 276,247 |
| 市值 | 683.20M |
| 贝塔系数 | 0.970 |
| RSI（14日） | 57.9 |
| 200日均线 | $17.75 |
| 50日均线 | $20.40 |
| 52周最高 | $27.29 |
| 52周最低 | $13.09 |
| Forward P/E | 16.05 |
| Price / Book | 25.89 |
🎯 投资策略评分
ETON 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🚀 Moon Shot (66/100) — 此策略 高增长潜力（高贝塔 + 超卖）.
评分最低的策略： 🐋 Institutional Whale (19/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 ETON in your text
粘贴任何文章、记录或帖子 — 工具将提取 ETON 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.